Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.15 | N/A |
| PEG Ratio (TTM) | 0.77 | N/A |
| P/S Ratio (TTM) | 9.50 | N/A |
| P/B Ratio (TTM) | 1.07 | N/A |
| P/FCF Ratio (TTM) | 3.86 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.44% | N/A |
| ROE (TTM) | 7.12% | N/A |
| Net Profit Margin (TTM) | 368.27% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 41.10% | 217.76% | N/A |
| Revenue | -4.29% | 356.44% | N/A |
| Net Income | 45.15% | 266.24% | N/A |
| Cash Flow | N/A | 235.39% | N/A |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.85 | N/A |
| Quick Ratio (TTM) | 2.85 | N/A |
| D/E Ratio (TTM) | 0.13 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 1.15 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |